|
Market Closed -
Nasdaq
16:00:00 2026-08-26 EDT
|
5-day change | 1st Jan Change | ||
| 12.70 USD | -2.08% |
|
-6.55% | -31.20% |
| 08-14 | Oppenheimer Adjusts Price Target on MediWound to $30 From $32, Keeps Outperform Rating | MT |
| 08-13 | MediWound Ltd., Q2 2026 Earnings Call, Aug 13, 2026 |
| Market Cap | 164M 141M 132M 121M 228M 15.64B 229M 1.56B 606M 7.89B 616M 602M 26.13B | P/E 2026 * |
-5.79x | P/E 2027 * | -5.78x |
|---|---|---|---|---|---|
| Enterprise Value | 164M 141M 132M 121M 228M 15.64B 229M 1.56B 606M 7.89B 616M 602M 26.13B | EV / Sales 2026 * |
6.93x | EV / Sales 2027 * | 5.16x |
| Free-Float |
84.04% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript : MediWound Ltd.
| 1 day | -2.08% | ||
| 1 week | -6.55% | ||
| Current month | -10.06% | ||
| 1 month | -10.75% | ||
| 3 months | -23.86% | ||
| 6 months | -27.51% | ||
| Current year | -31.20% |
| 1 week | 12.61 |  | 13.32 |
| 1 month | 12.61 | | 14.87 |
| Current year | 12.61 | | 19.7 |
| 1 year | 12.61 | | 20.3 |
| 3 years | 7.1 | | 24 |
| 5 years | 7.1 | | 28.07 |
| 10 years | 7.1 | | 60.06 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ofer Gonen
CEO | Chief Executive Officer | 52 | 2022-06-29 |
Hani Luxenburg
DFI | Director of Finance/CFO | 54 | 2023-05-13 |
Liron Gal
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Vickie R. Driver
BRD | Director/Board Member | 72 | 2017-05-17 |
Stephen Wills
CHM | Chairman | 69 | 2017-10-24 |
David Fox
BRD | Director/Board Member | 68 | 2020-04-26 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.08% | -6.55% | -24.58% | +43.83% | 164M | |
| -2.25% | -3.10% | +38.65% | -1.87% | 81.36B | |
| -5.77% | -14.18% | +505.18% | +33.71% | 59.75B | |
| +0.84% | +4.44% | -19.19% | -35.11% | 59.19B | |
| +0.76% | +3.53% | +0.08% | +36.18% | 53.33B | |
| +2.22% | +3.76% | +12.38% | +175.13% | 49.09B | |
| +0.14% | -0.22% | +61.70% | -16.40% | 32.66B | |
| -1.23% | -0.27% | +52.52% | +100.63% | 25.97B | |
| -2.00% | +6.32% | +18.24% | +209.64% | 24.39B | |
| +0.90% | +0.39% | +61.40% | +123.21% | 16.91B | |
| Average | -0.40% | -0.51% | +70.64% | +66.89% | 40.28B | |
| Weighted average by Cap. | -0.31% | -1.01% | +93.50% | +48.64% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 23.67M 20.32M 19.07M 17.42M 32.87M 2.26B 33.03M 226M 87.47M 1.14B 88.89M 86.96M 3.77B | 31.81M 27.3M 25.62M 23.4M 44.17M 3.03B 44.38M 303M 118M 1.53B 119M 117M 5.07B |
| Net income | -29.11M -24.98M -23.45M -21.42M -40.42M -2.78B -40.62M -278M -108M -1.4B -109M -107M -4.64B | -31.82M -27.31M -25.63M -23.41M -44.18M -3.03B -44.4M -303M -118M -1.53B -119M -117M -5.07B |
| Net Debt | - | - |
| Date | Price | Change |
|---|---|---|
| 26-08-26 | US$12.70 | -2.08% |
| 26-08-25 | US$12.97 | -0.23% |
| 26-08-24 | US$13.00 | -1.59% |
| 26-08-21 | US$13.21 | +0.72% |
| 26-08-20 | US$13.12 | -3.50% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- MDWD Stock
Select your edition
All financial news and data tailored to specific country editions
